Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Marandino

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
European Urology|June 21, 2021
Primary Renal Tumour Response to Immunotherapy: Lessons from Metastatic Disease and Insights into Earlier SettingsLaura Marandino, Andrea Necchi
Mediastinum (Hong Kong, China)|March 28, 2022
Mediastinal germ cell tumours: where we are and where we are going-a narrative reviewLaura Marandino, Ursula Maria Vogl
Current Opinion in Urology|February 25, 2025
Cytoreductive nephrectomy for oligometastatic clear cell renal cell carcinoma in the era of immuno-oncologyLaura Marandino, Veronica Mollica, Riccardo Campi, et al.
European Urology|March 6, 2022
Neoadjuvant Treatment in Renal Cell Carcinoma: Transforming Challenges into OpportunitiesLaura Marandino, Daniele Raggi, Andrea Necchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2022
Impact of Novel Hormonal Therapy on Cognitive Function: Essential to Measure, Difficult to PresentLaura Marandino, Daniele Raggi, Andrea Necchi, et al.
JCO Oncology Practice|May 5, 2020
COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical PracticeLaura Marandino, Andrea Necchi, Massimo Aglietta, et al.
Minerva Urology and Nephrology|March 31, 2023
The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive diseaseLaura Marandino, Chiara Ciccarese, Giulio Francolini, et al.
Expert Review of Anticancer Therapy|September 24, 2019
Erdafitinib for the treatment of urothelial cancerLaura Marandino, Daniele Raggi, Patrizia Giannatempo, et al.
BJU International|November 13, 2025
Awareness and perspectives on hereditary renal cell carcinoma and genetic testing in clinical practice: a multi-national surveyChiara Re, Daniele Amparore, Riccardo Campi, et al.
Minerva Urology and Nephrology|April 23, 2026
YAU-RCC insights from ESMO 2025: time to refine systemic treatment strategies in renal cell carcinomaLaura Marandino, Veronica Mollica, Daniele Amparore, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
European Urology|June 21, 2021
Primary Renal Tumour Response to Immunotherapy: Lessons from Metastatic Disease and Insights into Earlier SettingsLaura Marandino, Andrea Necchi
Mediastinum (Hong Kong, China)|March 28, 2022
Mediastinal germ cell tumours: where we are and where we are going-a narrative reviewLaura Marandino, Ursula Maria Vogl
Current Opinion in Urology|February 25, 2025
Cytoreductive nephrectomy for oligometastatic clear cell renal cell carcinoma in the era of immuno-oncologyLaura Marandino, Veronica Mollica, Riccardo Campi, et al.
European Urology|March 6, 2022
Neoadjuvant Treatment in Renal Cell Carcinoma: Transforming Challenges into OpportunitiesLaura Marandino, Daniele Raggi, Andrea Necchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2022
Impact of Novel Hormonal Therapy on Cognitive Function: Essential to Measure, Difficult to PresentLaura Marandino, Daniele Raggi, Andrea Necchi, et al.
JCO Oncology Practice|May 5, 2020
COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical PracticeLaura Marandino, Andrea Necchi, Massimo Aglietta, et al.
Minerva Urology and Nephrology|March 31, 2023
The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive diseaseLaura Marandino, Chiara Ciccarese, Giulio Francolini, et al.
Expert Review of Anticancer Therapy|September 24, 2019
Erdafitinib for the treatment of urothelial cancerLaura Marandino, Daniele Raggi, Patrizia Giannatempo, et al.
BJU International|November 13, 2025
Awareness and perspectives on hereditary renal cell carcinoma and genetic testing in clinical practice: a multi-national surveyChiara Re, Daniele Amparore, Riccardo Campi, et al.
Minerva Urology and Nephrology|April 23, 2026
YAU-RCC insights from ESMO 2025: time to refine systemic treatment strategies in renal cell carcinomaLaura Marandino, Veronica Mollica, Daniele Amparore, et al.
Pageof 12